SCIENTIFIC HUB

Follow the evidence.

18.369 articles found

Source record

Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's disease.

Yssel JD, O'Neill E, Nolan YM, Connor TJ, Harkin A.

Brain Behav Immun · 2018-01-12

DOI: 10.1016/j.bbi.2018.01.004PMID: 29339319

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.